Does LENALIDOMIDE Cause Mantle cell lymphoma? 179 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 179 reports of Mantle cell lymphoma have been filed in association with LENALIDOMIDE (LENALIDOMIDE). This represents 0.1% of all adverse event reports for LENALIDOMIDE.
179
Reports of Mantle cell lymphoma with LENALIDOMIDE
0.1%
of all LENALIDOMIDE reports
120
Deaths
29
Hospitalizations
How Dangerous Is Mantle cell lymphoma From LENALIDOMIDE?
Of the 179 reports, 120 (67.0%) resulted in death, 29 (16.2%) required hospitalization, and 8 (4.5%) were considered life-threatening.
Is Mantle cell lymphoma Listed in the Official Label?
Yes, Mantle cell lymphoma is listed as a known adverse reaction in the official FDA drug label for LENALIDOMIDE.
What Other Side Effects Does LENALIDOMIDE Cause?
Diarrhoea (27,576)
Fatigue (22,956)
Death (19,213)
Off label use (17,017)
Rash (15,794)
Pneumonia (14,807)
Plasma cell myeloma (14,191)
Neuropathy peripheral (10,215)
White blood cell count decreased (9,996)
Constipation (9,635)
What Other Drugs Cause Mantle cell lymphoma?
RITUXIMAB (352)
IBRUTINIB (321)
BORTEZOMIB (184)
VENETOCLAX (174)
CYCLOPHOSPHAMIDE (120)
CYTARABINE (114)
VINCRISTINE (112)
BENDAMUSTINE (109)
DOXORUBICIN (108)
PREDNISONE (96)
Which LENALIDOMIDE Alternatives Have Lower Mantle cell lymphoma Risk?
LENALIDOMIDE vs LENIOLISIB
LENALIDOMIDE vs LENOGRASTIM
LENALIDOMIDE vs LENVATINIB
LENALIDOMIDE vs LEPONEX
LENALIDOMIDE vs LERCANIDIPINE